Amgen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	7,800	7,711	4,090	6,717	6,552	5,893
Depreciation & Amortization	4,896	5,167	5,592	4,071	3,417	3,398
Stock-Based Compensation	484	494	530	431	401	341
Other Adjustments	-741	-1,436	-1,087	-2,264	84	823
Change in Receivables	-955	-2,676	441	-1,015	-746	-429
Changes in Inventories	616	886	2,532	491	-742	-165
Changes in Accounts Payable	502	428	312	-402	154	-69
Changes in Accrued Expenses	414	499	92	953	97	-
Changes in Income Taxes Payable	-2,101	-2,068	-1,011	-1,031	-647	-854
Changes in Other Operating Activities	-159	953	-1	520	1,151	323
Operating Cash Flow	10,756	9,958	11,490	8,471	9,721	9,261
Operating Cash Flow Growth	-11.78%	-13.33%	35.64%	-12.86%	4.97%	-11.77%
Capital Expenditures	-2,159	-1,858	-1,096	-1,112	-936	-880
Purchases of Investments	-	-	-	-	-2,587	-8,900
Proceeds from Sale of Investments	-	-	-	1,673	1,218	13,234
Cash Acquisitions	-	-53	-	-26,989	-3,839	-2,529
Other Investing Activities	-	-32	50	224	100	-192
Investing Cash Flow	-2,212	-1,943	-1,046	-26,204	-6,044	733
Long-Term Debt Issued	3,964	-	-	27,777	6,919	4,945
Long-Term Debt Repaid	-3,948	-5,683	-4,259	-2,101	-297	-4,150
Net Long-Term Debt Issued (Repaid)	16	-5,683	-4,259	25,676	6,622	795
Repurchase of Common Stock	-	-	-200	-	-6,360	-4,975
Net Common Stock Issued (Repurchased)	-	-	-200	-	-6,360	-4,975
Common Dividends Paid	-5,203	-5,124	-4,832	-4,556	-4,196	-4,013
Other Financing Activities	-129	-52	-124	-72	-103	-78
Financing Cash Flow	-5,316	-10,859	-9,415	21,048	-4,037	-8,271
Net Cash Flow	3,228	-2,844	1,029	3,315	-360	1,723
Free Cash Flow	8,597	8,100	10,394	7,359	8,785	8,381
Free Cash Flow Growth	-21.24%	-22.07%	41.24%	-16.23%	4.82%	-15.25%
FCF Margin	23.10%	22.04%	31.10%	26.11%	33.37%	32.26%
Free Cash Flow Per Share	15.85	14.94	19.21	13.68	16.24	14.63
Levered Free Cash Flow	9,825	6,035	6,251	35,883	15,668	8,441
Unlevered Free Cash Flow	11,080	11,807	12,861	10,243	11,026	8,471

SEC Filings: 10-K · 10-Q